Efficacy and Indications of Fenelidone Tablets: Which diseases and symptoms are used to treat

Finerenone is a new mineralocorticoid receptor antagonist (MRA) that has significant efficacy in treating high blood pressure associated with chronic kidney disease and kidney problems associated with diabetes. It helps patients control the disease and delay disease progression by selectively antagonizing mineral corticosteroid receptors, reducing salt and water retention, and reducing the burden on the kidneys and heart. The following are the main functions and indications of fenelinone.

One of the main applications of fenelidone is in the treatment of chronic kidney disease (CKD) caused by diabetes. Diabetic patients often suffer from renal tubular damage caused by high blood sugar, leading to a gradual deterioration of kidney function. Fenelidone can effectively slow down the progression of kidney disease by antagonizing mineralocorticoid receptors and reducing inflammation, fibrosis and damage in the kidneys. Clinical studies have shown that fenelidone can significantly reduce urinary protein excretion, which is of great significance for controlling renal lesions and improving patients' quality of life.

Fenelidone is also used to treat high blood pressure caused by chronic kidney disease. Patients with chronic kidney disease often suffer from high blood pressure due to impaired kidney function. Fenelidone can effectively control blood pressure by reducing the effects of mineralocorticoids and reducing water and sodium retention, especially in patients who are ineffective in conventional drug treatments. It not only improves blood pressure control but also reduces the risk of cardiovascular events, which is especially important for patients who need to control high blood pressure.

In addition to renal and hypertension treatment, fenelidone also has certain cardiovascular protective effects. Chronic kidney disease and hypertension tend to increase patients' cardiovascular risks, particularly the incidence of heart failure and coronary heart disease. Fenelidone helps reduce the risk of these cardiovascular events by reducing the negative effects of mineralocorticoids and improving heart function and vascular health. Clinical data show that fenelidone can reduce the incidence of heart failure and improve long-term survival rates in patients with diabetes and chronic kidney disease.

Reference materials:https://www.kerendia.com/